Stay updated with breaking news from Bruno Maranda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A cocktail of antibodies developed by Quebec firm Immune Biosolutions has reportedly proved effective in alleviating the respiratory symptoms caused by COVID-19 during the acute phase of the virus.
Monoclonal antibodies that millions of Americans rely on to treat the coronavirus are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are more potent and more resistant to new variants.
Lab-made therapies are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are both more potent and more resistant to new variants.
/CNW Telbec/ - Immune Biosolutions is pleased to announce the start of Phase I clinical trial for its immunotherapy (IBIO123) treatment, whose antibodies have...